Postoperative outcomes in living donor liver transplant vs. deceased donor liver transplant in patients with metabolic dysfunction-associated steatohepatitis: a UNOS database analysis
LDLT for patients with MASH allows this medically comorbid patient population safe access to transplantation at an earlier and less decompensated disease stage and lower MELD with improved survival.
Authors
- Todd J. Robinson (ORCID: https://orcid.org/0000-0001-5230-8435)
- Paola A. Vargas (ORCID: https://orcid.org/0000-0002-8038-6665)
- José Oberholzer (ORCID: https://orcid.org/0000-0002-1069-2501)
- Nicolás Goldaracena (ORCID: https://orcid.org/0000-0002-6623-5561)
- Abdulghani Abou Koura (ORCID: https://orcid.org/0009-0008-8120-115X)
- Maurus P. Steigmeier
- Shawn J. Pelletier (ORCID: https://orcid.org/0000-0002-1499-016X)
Institutions
- NewYork–Presbyterian Hospital (US)
- Johns Hopkins University (US)
- University of Zurich (CH)
- Cornell University (US)
- University of Virginia Health System (US)
- Johns Hopkins Medicine (US)
- Presbyterian Hospital (US)
Publication Details
- Journal
- HepatoBiliary Surgery and Nutrition
- Published
- 2024-12-11
- DOI
- https://doi.org/10.21037/hbsn-24-319
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00